Abstract:Boron-dipyrromethene (BODIPY) dyes have aroused considerable interest in cancer theranostics over the past decade because of robust photochemical properties. Although a large number of BODIPY photosensitizers (PSs) containing heavy atoms have been reported, the development of heavy-atom-free BODIPY PSs for oncologic photodynamic therapy (PDT) has been limited mainly by the uncertainty in intersystem crossing (ISC) mechanisms, unbalanced phototoxic effectiveness and fluorescence quantum yields, and aggregation-caused quenching effects. In addition, the lack of extensive in vivo studies of heavy-atom-free BODIPY PSs continues to limit clinical application. Herein, novel heavy-atom-free BODIPY-phenoxazine triads (BDP-8/BDP-9) that generate efficient excited triplet states via radical pair intersystem crossing (RP-ISC) followed by triplet charge recombination were developed for use in fluorescence image-guided PDT. BDP-8/BDP-9 exhibited high molar absorption coefficients, prominent aggregation-induced emission, and excellent singlet oxygen generation capability upon light irradiation. The corresponding BODIPY nanoparticles (BDP-8/BDP-9 NPs) with bright red emission, considerable phototoxicity, and excellent tumor-targeting ability were simply prepared by encapsulating BDP-8/BDP-9 PSs in a polymeric matrix. More importantly, the results of both in vitro and in vivo experiments demonstrated the considerable potential of BDP-8 NPs for image-guided photodynamic cancer therapy. This study may inspire the development of potential BODIPY-based nanoagents for cancer theranostics.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.chemmater.1c02776.Experimental data; synthesis, nanoparticle preparation, photophysical measurements, and reactive oxygen species measurements of BDP-8/BDP-9; in vitro and in vivo studies of BDP-8/BDP-9 NPs; 1H and 13C NMR spectra of all compounds; UV–vis absorption and PL spectra; fluorescence images; computational details, calculated electronic transition energies; energy gap between single and triplet states; spin-orbit coupling constant; and intersystem crossing rate constant (PDF)This article has not yet been cited by other publications.

First-principles design of heavy-atom-free singlet oxygen photosensitizers for photodynamic therapy

Recent Development of Heavy Atom-Free Triplet Photosensitizers for Photodynamic Therapy

Heavy Atom-Free Triplet Photosensitizers: Molecular Structure Design, Photophysical Properties and Application in Photodynamic Therapy

Regulating 1 O 2 generation from heavy-atom-free triplet photosensitizers based on thiophene-fused BODIPY

Rational design of type-I photosensitizer molecules for mitochondrion-targeted photodynamic therapy

In Silico Investigation of a Series of D-A-D Structured Chain Thiophene Photosensitizers for Photodynamic Therapy

Aromaticity Tuning of Heavy-Atom-Free Photosensitizers for Singlet Fission-Enhanced Immunogenic Photodynamic Oncotherapy

Achieving Beyond 100% Triplet State Generation with Singlet Fission Strategy for High-Performance Photosensitizer Design

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

New Cy5 Photosensitizers for Cancer Phototherapy: a Low Singlet-Triplet Gap Provides High Quantum Yield of Singlet Oxygen.

Singlet Oxygen in Photodynamic Therapy

Asymmetric A‐DA′D‐A′′ Molecular Configuration Type‐I Photosensitizer with Two Complementary Reactive Oxygen Species for Efficient Imaging and Photodynamic Therapy

Highly Efficient Photosensitizers with Molecular Vibrational Torsion for Cancer Photodynamic Therapy

Molecular Engineering Design of Twisted-backbone Pure Type-I Organic Photosensitizers for Hypoxic Photodynamic Therapy

Site-selected thionated benzothioxanthene chromophores as heavy-atom-free small-molecule photosensitizers for photodynamic therapy

A Design Strategy of Pure Type-I Thiadiazolo[3,4-G]quinoxaline-based Photosensitizers for Photodynamic Therapy

Strategies to construct efficient singlet oxygen-generating photosensitizers

Cationization to boost both type I and type II ROS generation for photodynamic therapy

Access to the Triplet Excited States of Heavy-Atom-Free Boron-Dipyrromethene Photosensitizers via Radical Pair Intersystem Crossing for Image-Guided Tumor-Targeted Photodynamic Therapy

Octachloro-fluorescein: Synthesis and Photosensitizer Performance Evaluation

A Combination of Covalent and Noncovalent Restricted-Intramolecular-rotation Strategy for Supramolecular AIE-type Photosensitizer Toward Photodynamic Therapy